MEDITOPE-ENABLED T CELLS

Provided herein are compositions which exhibit novel therapeutic capabilities and allow to reduce the off-target effect of therapeutic antibodies. The compositions include recombinant proteins that if expressed by a T cell can efficiently recruit therapeutic antibodies to their site of action.

Saved in:
Bibliographic Details
Main Authors WILLIAMS, John, C, KUO, Cheng-Fu, BROWN, Christine, JENKINS, Kurt, KUO, Yi-Chiu
Format Patent
LanguageEnglish
French
German
Published 04.11.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided herein are compositions which exhibit novel therapeutic capabilities and allow to reduce the off-target effect of therapeutic antibodies. The compositions include recombinant proteins that if expressed by a T cell can efficiently recruit therapeutic antibodies to their site of action.
Bibliography:Application Number: EP20180896671